Best Lactobacillus reuteri DSM 17938 Supplements for Gut Health (2026)

L. reuteri DSM 17938 is a gram-positive, heterofermentative lactic acid bacterium that colonizes the human gastrointestinal tract. It produces several antimicrobial compounds, most notably reuterin (3-hydroxypropionaldehyde), which can inhibit the growth of pathogenic bacteria, fungi, and protozoa without broadly disrupting commensal flora. This selective antimicrobial activity is one mechanism through which DSM 17938 may help restore or maintain a balanced gut environment. Beyond direct antimicrobial action, DSM 17938 appears to modulate gut motility signaling and may influence the gut-brain axis through effects on serotonin precursor availability and enteric nervous system communication — though much of this mechanistic work is still being characterized in human studies. The strain also interacts with intestinal epithelial cells and immune-sensing tissues in the gut wall, supporting barrier integrity in ways that several other well-studied probiotic strains share. What's relatively unique to DSM 17938 is the consistency of the dose used across trials: 10^8 CFU, not the 10^10 or 10^11 CFU common to other probiotic research, suggesting its mechanisms operate effectively at lower colonization densities.

The single most important decision you'll make buying an L. reuteri supplement is confirming the strain designation. 'L. reuteri' on a label without a strain code tells you almost nothing about what that organism will do. The human clinical evidence for colic reduction, constipation support, and other gut outcomes is specifically tied to DSM 17938 — not to L. reuteri as a species. Think of it like aspirin versus a random anti-inflammatory: same class, very different data profiles. Second, don't be seduced by high CFU counts. The research on DSM 17938 consistently uses 100 million CFU (10^8). That's not a minimum — it's the studied dose. There's no peer-reviewed evidence that 10 billion CFU of DSM 17938 outperforms 100 million CFU for gut outcomes. In fact, taking a dose far outside the studied range means you're essentially running an uncontrolled personal experiment. If strain-specific evidence matters to you, dose-matching matters too. Format is worth thinking about more than most buyers do. Oil-based drops have the advantage of flexibility — you can add them to milk, formula, or food — but they require refrigeration after opening and careful dosing. Chewable tablets are more consistent per dose and genuinely convenient, but the oral-exposure format means some organisms are neutralized before reaching the stomach. Capsules (particularly delayed-release or enteric-coated versions) tend to deliver better viable cell counts to the lower intestine, but DSM 17938 isn't currently available in a verified capsule format from BioGaia. Finally, price transparency matters. Products listing proprietary blends with undisclosed per-strain doses make it impossible to evaluate value. If a product won't tell you how much L. reuteri DSM 17938 is in each serving, that's not a minor omission — it's a reason to look elsewhere.